One session treatment for specific phobias in children: Comorbid anxiety disorders and treatment outcome

One session treatment for specific phobias in children: Comorbid anxiety disorders and treatment outcome
复制标题

DOI:
10.1016/j.jbtep.2016.07.011
复制
发表时间:
2017-03-01
影响因子:
1.8
通讯作者:
Ollendick, Thomas H.
Ollendick, Thomas H.
中科院分区:
医学3区
文献类型:
--
作者:
Ryan, Sarah M.;Strege, Marlene V.;Ollendick, Thomas H.

文献摘要

被引文献

相似文献

Background and objectives: One-Session Treatment (OST) for specific phobias has been shown to be effective in reducing phobia severity; however, the effect of different types of co-occurring anxiety disorders on OST outcomes is unknown. The present study examined (1) the effects of co-occurring generalized anxiety disorder (GAD), social anxiety disorder (SAD), or another non-targeted specific phobia (OSP) on the efficacy of OST for specific phobias, and (2) the effects of OST on these co-occurring disorders following treatment.Methods: Three groups of 18 youth (7-15 years) with a specific phobia and comorbid GAD, SAD, or OSP were matched on age, gender, and phobia type. Outcome measures included diagnostic status and severity, and clinician rated improvement.Results: All groups demonstrated an improvement in their specific phobia following treatment. Treatment was equally effective regardless of co-occurring anxiety disorder. In addition, comorbid anxiety disorders improved following OST; however, this effect was not equal across groups. The SAD group showed poorer improvement in their comorbid disorder than the GAD group post-treatment. However, the SAD group continued to improve and this differential effect was not evident six-months following treatment. Limitations: The current study sample was small, with insufficient power to detect small and medium effect sizes. Further, the sample only included a portion of individuals with primary GAD or SAD, which may have attenuated the findings.Conclusions: The current study demonstrated that co-occurring anxiety disorders did not interfere with phobia treatment. OST, despite targeting a single specific phobia type, significantly reduced comorbid symptomatology across multiple anxiety disorders. (C) 2016 Elsevier Ltd. All rights reserved.